We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AXDX market cap is 29.05M. The company's latest EPS is USD -2.4604 and P/E is -0.47.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.3M | 3.03M | 2.92M | 2.99M | 2.98M |
Operating Income | -14.65M | -10.73M | -10.16M | -8.61M | -8.62M |
Net Income | 910k | -13M | -14.23M | -11.59M | -14.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 9.3M | 11.17M | 11.78M | 12.75M | 12.06M |
Operating Income | -72.83M | -63.7M | -71.56M | -62.81M | -54.03M |
Net Income | -84.31M | -78.21M | -77.7M | -62.49M | -61.62M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 39.32M | 31.37M | 30.72M | 22.87M | 32.32M |
Total Liabilities | 74.36M | 51.25M | 56.5M | 57.75M | 80.8M |
Total Equity | -35.03M | -19.89M | -25.78M | -34.89M | -48.48M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 134.42M | 93.43M | 83.05M | 65.02M | 31.37M |
Total Liabilities | 141.8M | 156.24M | 118.12M | 87.28M | 51.25M |
Total Equity | -7.38M | -62.81M | -35.07M | -22.26M | -19.89M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -32.44M | -40.2M | -8.45M | -16.04M | -19.13M |
Investing | 8.77M | 8.66M | -513k | -515k | -509k |
Financing | 8.91M | 9.02M | 11.44M | 12.84M | 27.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -64.79M | -50.39M | -47.32M | -48.73M | -40.2M |
Investing | 52.81M | 13.61M | 8.3M | 12.42M | 8.66M |
Financing | 6.82M | 11.63M | 43.23M | 31.63M | 9.02M |
Market Cap | 29.05M |
Price to Earnings Ratio | -0.47 |
Price to Sales Ratio | 2.41 |
Price to Cash Ratio | 2.39 |
Price to Book Ratio | -1.46 |
Dividend Yield | - |
Shares Outstanding | 25.04M |
Average Volume (1 week) | 104.77k |
Average Volume (1 Month) | 66.85k |
52 Week Change | -74.56% |
52 Week High | 4.675 |
52 Week Low | 0.73 |
Spread (Intraday) | 3.94 (78.8%) |
Company Name | Accelerate Diagnostics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://ir.axdx.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions